Volume 27, Issue 3 - Editing

Anonymisation: A new challenge for medical writers

Authors: Montserrat Cuadrado Lafoz, Anna Ramírez- Soriano, Sarah J. Richardson

Abstract

Download the full article

References

1. EMA. EMA policy on access to documents (related to medicinal products for human and veterinary use). Policy/0043 (EMA/110196/2006). 2010 [cited 2018 Jun 13]. Available from: http://www.ema.europa.eu/docs/en_GB/ document_library/Other/2010/11/ WC500099473.pdf.
2. EMA. EMA policy on publication of clinical data for medicinal products for human use. Policy/0070 (EMA/240810/ 2013). 2014 [cited 2018 Jun 13]. Available from: http://www.ema.europa.eu/docs/en_GB/ document_library/Other/2014/10/ WC500174796.pdf.
3. EMA. External guidance on the implementation of the EMA policy on the publication of clinical data for medicinal products for human use (EMA/90915/ 2016). 2017 [cited 2018 Jun 13]. Available from: http://www.ema.europa.eu/docs/envGB/ document_library/Regulatory_and_ procedural_guideline/2017/09/WC50023 5371.pdf.
4. Code of Federal Regulations. Title 45: Public Welfare, Subtitle A §164.514. [cited 2018 Jun 13]. Available from: https://www.gpo.gov/fdsys/pkg/CFR- 2002-title45-vol1/pdf/CFR-2002-title45- vol1-sec164-514.pdf.
5. Health Insurance Portability and Accountability Act Privacy Rule. [cited 2018 Jun 13]. Available from: https://www.hhs.gov/hipaa/forprofessionals/ privacy/index.html.
6. Council Regulation (EC) 45/2001 of the European Parliament and of the Council of 18 December 2000 on the protection of individuals with regard to the processing of personal data by the community institutions and bodies and on the free movement of such data. 2008 [cited 2018 Jun 13]. OJ L193/7. Available from: https://eur-lex. europa.eu/legal-content/EN/TXT/PDF/ ?uri=CELEX:32001R0045&from=EN.
7. Council Directive (EC) 95/46 of the European Parliament and of the Council of 24 October 1995 on the protection of individuals with regard to the processing of personal data and on the free movement of such data. 1995 [cited 2018 Jun 13]. OJ L281. Available from: https://ec.europa.eu/health/ sites/health/files/files/eudralex/vol-1/ reg_2014_536/reg_2014_536 _en.pdf.
8. Regulation (EU) 536/2014 of the European Parliament and of the Council of 16 April 2014 on clinical trials on medicinal products for human use, and repealing Directive 2001/20/EC. 2014 [cited 2018 Jun 13]. OJ L158/1. Available from: https://ec.europa.eu/health/sites/health/ files/files/eudralex/vol-1/reg_2014_536/ reg_2014_536_en.pdf.
9. Hrynaszkiewicz I, Norton ML, Vickers AJ, Altman DG. Preparing raw clinical data for publication: guidance for journal editors, authors, and peer reviewers. BMJ. 2010;340:c181.
10. Ferran JM, El Emam K, Nolan S, Grimm B, De Donder N. PhUSE De-Identification Working Group: Providing De- Identification Standards to CDISC Data Models. Presented at the PhUSE Annual Conference, Vienna, October 11-14, 2015 (Paper DH01). Available from: Available from: https://www.phusewiki.org/docs/ Conference%202015%20DH%20Papers/ DH01.pdf.
11. Kumar P, Sareen R. Evaluation of Reidentification Risk for Anonymized Clinical Documents. Presented at the PhUSE Annual Conference, Edinburgh, October 8-11, 2017 (Paper RG02). Available from: Available from: http://www.phusewiki.org/docs/ Conference%202017%20RG%20Papers/ RG02.pdf.
12. Data Protection Working Party. Opinion 05/2014 on Anonymisation Techniques. Article 29. WP 216. Available from: Available from: http://www.dataprotection.ro/servlet/ ViewDocument?id=1085.
13. Data Protection Working Party. Opinion 4/2007 on the Concept of Personal Data. Article 29. WP 136. Available from: Available from: https://www.clinicalstudydatarequest.com /Documents/Privacy-Europeanguidance. pdf.